These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38969094)

  • 1. The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD.
    Cheng Z; Yang L; Chu H
    J Adv Res; 2024 Jul; ():. PubMed ID: 38969094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
    Jung JH; Kim SE; Suk KT; Kim DJ
    Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Hong M; Han DH; Hong J; Kim DJ; Suk KT
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
    Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-based treatments in alcoholic liver disease.
    Sung H; Kim SW; Hong M; Suk KT
    World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
    Dong Y; Wu Z; Gai Z; Han M
    J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.
    Mutlu E; Keshavarzian A; Engen P; Forsyth CB; Sikaroodi M; Gillevet P
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1836-46. PubMed ID: 19645728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the gut barrier for the treatment of alcoholic liver disease.
    Zhou Z; Zhong W
    Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intake of Bifidobacterium lactis Probio-M8 fermented milk protects against alcoholic liver disease.
    He Q; Yang C; Kang X; Chen Y; Zhang T; Zhang H; Kwok LY
    J Dairy Sci; 2022 Apr; 105(4):2908-2921. PubMed ID: 35086715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
    Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis.
    Zhang H; Li C; Han L; Xiao Y; Bian J; Liu C; Gong L; Liu Z; Wang M
    Gut Microbes; 2024; 16(1):2367342. PubMed ID: 38889450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiome and Alcohol-associated Liver Disease.
    Philips CA; Schnabl B; Bajaj JS
    J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease.
    Chen L; Zhu Y; Hou X; Yang L; Chu H
    Front Med (Lausanne); 2022; 9():840752. PubMed ID: 35308525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk.
    Zhu L; Wang Y; Pan CQ; Xing H
    Front Pharmacol; 2023; 14():1258062. PubMed ID: 37601074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.